Nasdaq dreams aside, LYC must first focus on profitability

LYC has been loss-making since going into the healthcare business after businessman Lim Yin Chow first emerged in the company in 2016.

AFTER abandoning its plans to list its Singapore units on the Catalist board, LYC Healthcare Bhd has now set its sights on the Nasdaq Capital Markets.

The ACE-Market listed firm owns 64.5% of its Singaporean assets that are being floated on the Nasdaq Capital Markets.